Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of



 The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible
Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with
                the Sale of the Company to JLL Partners, Inc.

PR Newswire

NEW YORK, Feb. 1, 2013

NEW YORK, Feb. 1, 2013 /PRNewswire/ -- Levi & Korsinsky is investigating the
Board of Directors of BioClinica, Inc. ("BioClinica" or the "Company")
(NasdaqGM: BIOC) for possible breaches of fiduciary duty and other violations
of state law in connection with the sale of the Company to a holding company
controlled by JLL Partners, Inc.

(Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Click here to learn how to join the action:
http://zlk.9nl.com/bioclinica-bioc/, or call: 877-363-5972. There is no cost
or obligation to you.

Under the terms of the transaction, BioClinica shareholders will receive $7.25
for each share of BioClinica stock they own. The investigation concerns
whether the BioClinica Board of Directors breached their fiduciary duties to
BioClinica stockholders by failing to adequately shop the Company before
entering into this transaction and whether JLL Partners, Inc. is underpaying
for BioClinica shares, thus unlawfully harming BioClinica stockholders. In
particular, at least one analyst set a price target for BioClinica stock at
$9.00 per share.

If you own common stock in BioClinica and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972,
http://zlk.9nl.com/bioclinica-bioc/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. The attorneys at Levi &
Korsinsky have been appointed by numerous courts throughout the country to
serve as lead counsel on behalf of shareholders in major securities lawsuits
and have successfully recovered multimillion-dollar damages awards on behalf
of investors. For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement